Elevance Health Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Gail Koziara Boudreaux
- Full Time Employees
- 97,100
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Address
- 220 Virginia Avenue Indianapolis IN United States of America 46204
- IPO Date
- Oct 30, 2001
- CIK
- 0001156039
- Website
- elevancehealth.com
- Similar Companies
- Business
- Elevance Health Inc. (NYSE: ELV) operates as a leading health benefits company in the United States, providing a comprehensive portfolio of medical, dental, vision, pharmaceutical, behavioral health, long-term care, disability, and life insurance plans through affiliated brands including Anthem Blue Cross and Blue Shield in 14 states, Wellpoint Medicaid plans, Carelon services, Amerigroup, and others; it also delivers advanced healthcare solutions such as pharmacy benefit management via CarelonRx, clinical care coordination, digital health tools, primary care enablement, and whole-person care addressing social drivers of health. Headquartered in Indianapolis, Indiana, the company traces its origins to 1946 through predecessor entities like Anthem and WellPoint, which merged in 2004, and rebranded from Anthem Inc. to Elevance Health in June 2022 to reflect its focus on elevating health outcomes. Elevance Health serves approximately 47 million medical members nationwide, with operations spanning commercial employer-sponsored plans, individual coverage, Medicare Advantage, and Medicaid programs across multiple states including California, Florida, Georgia, Indiana, Kentucky, Missouri, New York, Ohio, Texas, and Puerto Rico via subsidiaries like MMM; it targets employers, individuals, families, government programs, and complex-needs populations through segments encompassing Health Benefits, CarelonRx, Carelon Services, and other corporate activities. The company has pursued aggressive expansion in specialty care and home-based services, including the 2024 acquisition of Paragon Healthcare for infusion therapies and CareBridge for home health management; it acquired Kroger Specialty Pharmacy in 2024 to bolster CarelonRx's infusion and mail-order capabilities, alongside earlier purchases of BioPlus Specialty Pharmacy and opening new dispensing centers. In April 2024, Elevance Health formed a strategic partnership with Clayton, Dubilier & Rice, integrating Carelon Health assets with apree health and Millennium Physician Group to innovate primary care delivery across U.S. regions. Recent initiatives encompass expanding behavioral health interventions and external partnerships under Carelon to manage medical costs, deepening AI integrations via a partnership with OpenAI announced in Q3 2025, scaling pharmacy home delivery and specialty services, enhancing Star ratings through member engagement, and broadening access to doula care and histotripsy treatments for liver tumors for over 45 million members; the company also rebranded Amerigroup to Wellpoint in 2024 and continues investing in digital automation and value-based care principles to drive long-term growth amid Medicaid dynamics.
Billionaire Investor Seth Klarman's Top 5 Stocks: Would He Buy More Today?
Bessemer Group Inc. Has $1.26 Million Holdings in Elevance Health, Inc. $ELV
Elevance Health, Inc. (NYSE:ELV) Given Consensus Rating of “Moderate Buy” by Brokerages
Acumen Wealth Advisors LLC Has $2.03 Million Stock Holdings in Elevance Health, Inc. $ELV
Artisan Value Fund Q2 2026 Portfolio Update
Elevance Health Chairman Ramiro Peru Buys $336,000 of Shares. What Does This Mean for Investors Right Now?
Elevance Health Q2 Earnings Call Highlights
Elevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook?
Big Hospital Systems Are Dropping Medicare Advantage Plans Mid-Contract. Patients Find Out by Letter
These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings
Elevance Health, Inc. (ELV) Q2 2026 Earnings Call Transcript
ELV Beats Q2 Earnings Estimates on Higher CarelonRx Product Revenues
Dow Jones Stays Calm While Memory Chips Give Investors Whiplash (Again)
Elevance Health Q2 Earnings Call Highlights
Compared to Estimates, Elevance Health (ELV) Q2 Earnings: A Look at Key Metrics
Elevance Health (ELV) Surpasses Q2 Earnings and Revenue Estimates
Elevance Health Profits Eclipse $1.4 Billion As Costs Ease Somewhat
Elevance Health Raises Earnings Outlook on Higher Sales
Elevance raises annual profit forecast on better medical cost management
Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance